The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Alkylating agents as first line chemotherapy in castration resistant prostate cancer: Is survival compromised? An analysis using an updater prognostic model in castration-resistant prostate cancer.
 
Matthew Mee
No Relationships to Disclose
 
Peter Wilson
No Relationships to Disclose
 
Wendy Ansell
No Relationships to Disclose
 
Jonathan Shamash
Honoraria - Astellas Pharma
Research Funding - Chugai Pharma
Travel, Accommodations, Expenses - Astellas Pharma